Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep Sequencing-Reference-Cited by-同舟云学术

Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep Sequencing

Published:2016-09-20 Issue:11 Volume:214 Page:1687-1694
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Kan Hiromi,Imamura Michio,Uchida Takuro,Hiraga Nobuhiko,Hayes C. Nelson,Tsuge Masataka,Abe Hiromi,Aikata Hiroshi,Makokha Grace Naswa,Chowdhury Sajeda,Miki Daiki,Ochi Hidenori,Ishida Yuji,Tateno Chise,Chayama Kazuaki

Funder

the Japan Agency for Medical Research and Development

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/214/11/1687/7705812/jiw437.pdf

Reference33 articles.

1. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

2. Prognosis of chronic hepatitis c: Results of a large, prospective cohort study

3. Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: The randomized PILLAR study

4. Simeprevir Increases Rate of Sustained Virologic Response Among Treatment-Experienced Patients With HCV Genotype-1 Infection: A Phase IIb Trial

5. Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-acting antivirals sofosbuvir and daclatasvir attenuate carbon tetrachloride-induced liver fibrosis in mice;Liver Research;2023-03

2. Laboratory Diagnosis;Hepatitis C: Epidemiology, Prevention and Elimination;2021

3. Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications;Scientific Reports;2020-05-18

4. Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy;Journal of Medical Virology;2019-10-16

5. High frequency of multiclass HCV resistance-associated mutations in patients failing direct-acting antivirals: real-life data;Antiviral Therapy;2019